Onyx Pharmaceuticals

onyx-pharm.com
+16502660000

Onyx Pharmaceuticals, Inc.

249 E. Grand Avenue
94080 South San Francisco
USA
+16502660000
onyx-pharm.com
Profile Products News

About Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. Our lead product is Nexavar® (sorafenib) tablets, a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis (the formation of new blood vessels to support cancer cell growth). This product is being developed and marketed in collaboration with Bayer HealthCare Pharmaceuticals.

Read more about Onyx Pharmaceuticals
Facts about Onyx Pharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Onyx Pharmaceuticals

Product portfolio

Show all

News about Onyx Pharmaceuticals

Onyx Pharmaceuticals

06-May-2010 | business & finance

S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors

S*BIO Pte Ltd and Onyx Pharmaceuticals, Inc. announced the expansion of their development collaboration and option and license commercialization agreement ...

Read news
Onyx Pharmaceuticals

27-Oct-2009 | research and development

Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that the companies have begun enrolling patients in an international Phase III trial to ...

Read news
Onyx Pharmaceuticals

24-Jul-2009 | research and development

Nexavar in Combination with Chemotherapy Shown To Extend Progression-Free Survival in Patients with Advanced Breast Cancer

Statistically Significant Results Reported from a Phase II Study Combining Two Oral Cancer Therapies

Read news
Onyx Pharmaceuticals

11-Nov-2008 | business & finance

BTG licenses novel anticancer compound to Onyx Pharmaceuticals

BTG to receive $13m upfront plus potential milestones of up to $307m and sales royalties

Read news
Onyx Pharmaceuticals

19-Aug-2008 | people

Onyx Pharmaceuticals Names Juergen Lasowski, Ph.D. as Senior Vice President of Corporate Development

Onyx Pharmaceuticals, Inc. announced the appointment of Dr. Juergen Lasowski as senior vice president of corporate development. In this role, Dr. Lasowski ...

Read news
Onyx Pharmaceuticals

02-Nov-2005 | research and development

Bayer and Onyx Announce Nexavar® (sorafenib tosylate) Tablets as Global Trade Name for Investigational Cancer Treatment

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc. announced the selection of Nexavar® (sorafenib tosylate) Tablets as the global trade name ...

Read news
Show more news about Onyx Pharmaceuticals

Here you will find Onyx Pharmaceuticals, Inc.